DEtermining Accuracy and TrEnding CharacTerization of AF

NCT ID: NCT01673256

Last Updated: 2019-02-05

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-09-30

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to assess the atrial fibrillation (AF) episode detection when using the SJM(St. Jude Medical) Confirm ICM (Implantable Cardiac Monitor).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SJM Confirm ICM Observational Group

SJM Confirm ICM

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SJM Confirm ICM

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The subject has been implanted with a SJM Confirm ICM, DM2102.
* The subject has or is suspected to have paroxysmal AF.
* The subject is ≥ 18 years of age.
* The subject is willing and able to provide written Informed Consent (prior to any investigational related procedure).

Exclusion Criteria

* The subject has persistent (\>7 days and ≤1 year or requiring cardioversion), longstanding persistent (continuous AF \>1 year) or permanent AF (not attempting to restore sinus rhythm).
* The subject has AF of reversible etiology (e.g. electrolyte imbalance, thyroid disease).
* The subject has a contraindication to Holter recording.
* The subject has already received an active implantable medical device other than the SJM Confirm ICM, DM2102.
* The subject is unable to comply with the follow up schedule.
* The subject is participating in another investigational device or drug investigation.
* The subject is pregnant or is planning to become pregnant during the duration of the investigation.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abbott Medical Devices

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thorsten Lewalter, MD

Role: PRINCIPAL_INVESTIGATOR

Isar Heart Center Munich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rhön-Klinikum, Herz- und Gefäß-Klinik

Bad Neustadt an der Saale, , Germany

Site Status

Herz -und Diabeteszentrum

Bad Oeynhausen, , Germany

Site Status

Charite, Campus Virchow-Klinikum

Berlin, , Germany

Site Status

Klinikum Coburg

Coburg, , Germany

Site Status

University of Dresden - Heart Center

Dresden, , Germany

Site Status

Klinikum Frankfurt Höchst GmbH

Frankfurt, , Germany

Site Status

Klinikum Ingolstadt GmbH

Ingolstadt, , Germany

Site Status

Herzzentrum Leipzig

Leipzig, , Germany

Site Status

Isar Heart Center

Munich, , Germany

Site Status

Hegau-Bodensee-Kliniken

Singen, , Germany

Site Status

Schwarzwald-Baar Klinikum GmbH

Villingen-Schwenningen, , Germany

Site Status

Albert Schweitzer Hospital

Dordrecht, , Netherlands

Site Status

Hagahospital

The Hague, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DETECT AF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Safety and Efficacy Study of RENEWAL 4 AVT
NCT00180336 COMPLETED PHASE2/PHASE3